Camber Capital Management LP 13D and 13G filings for PTC Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 08:35 am Sale |
2024-12-31 | 13G | PTC Therapeutics, Inc. PTCT |
Camber Capital Management LP | 3,200,000 4.150% |
-800,000 (-20.00%) |
Filing |
| 2023-10-30 09:05 am Purchase |
2023-10-19 | 13G | PTC Therapeutics, Inc. PTCT |
Camber Capital Management LP | 4,000,000 5.310% |
4,000,000 (New Position) |
Filing |